Gilead Prices $2B Senior Unsecured Notes; $1B Of 5.250% Senior Notes Maturing In 2033 And $1B Of 5.550% In 2053
Portfolio Pulse from Benzinga Newsdesk
Gilead Sciences has priced $2 billion in senior unsecured notes, split into two tranches: $1 billion of 5.250% senior notes maturing in 2033 and $1 billion of 5.550% senior notes maturing in 2053.
September 08, 2023 | 6:25 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences has issued $2 billion in senior unsecured notes. This could impact the company's leverage and interest expenses.
The issuance of $2 billion in senior unsecured notes by Gilead Sciences could potentially increase the company's leverage and interest expenses. However, it could also provide the company with additional capital for operations or strategic initiatives. The impact on the stock price will depend on how investors interpret this move.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100